InvestSMART

Truscreen Group Limited (ASX: TRU) - Announcements

- Current share price for TRU : $0.012

ASX company news and announcements for Truscreen Group Limited (TRU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Truscreen Group Limited (TRU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Truscreen Group Limited (TRU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Truscreen Group Limited (TRU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13 TruScreen Presentation ASX Small and Mid-Cap Conference 27 Mar 2024 8:06AM $0.020 $0.012 fallen by 40%
$13 Change of Directors Interest Notice X 3 22 Mar 2024 1:27PM $0.020 $0.012 fallen by 40%
$13 Appendix 2A 20 Mar 2024 11:20AM $0.020 $0.012 fallen by 40%
$13 Results of Placement and Rights Offer 18 Mar 2024 8:40AM $0.020 $0.012 fallen by 40%
$13 Truscreen Raises Additional NZ$520,000 in Share Placement 13 Mar 2024 12:36PM $0.019 $0.012 fallen by 36.84%
$13 TruScreen Market Access Developments - Indonesia and Kenya 8 Mar 2024 7:32AM $0.019 $0.012 fallen by 36.84%
$13 Truscreen Raises NZ$500,000 in Share Placement 4 Mar 2024 8:30AM $0.020 $0.012 fallen by 40%
$13 TruScreen Group Limited Fact Sheet 28 Feb 2024 2:31PM $0.020 $0.012 fallen by 40%
$13 Investor Presentation Update 28 Feb 2024 8:30AM $0.020 $0.012 fallen by 40%
$13 Resignation of CEO and Appointment Interim CEO 23 Feb 2024 8:10AM $0.024 $0.012 fallen by 50%
$13 Rights Issue Offer Document 20 Feb 2024 8:50AM $0.025 $0.012 fallen by 52%
$13 Cleansing Notice 12 Feb 2024 11:58AM $0.028 $0.012 fallen by 57.14%
$13 Truscreen to Launch Pro Rata Renounceable Rights Issue 12 Feb 2024 11:58AM $0.028 $0.012 fallen by 57.14%
$13 Reimbursement Approval from Health Insurers in Saudi Arabia 12 Feb 2024 8:53AM $0.028 $0.012 fallen by 57.14%
$13 Approval in Mexico to Enter Public Health Sector 7 Feb 2024 8:57AM $0.022 $0.012 fallen by 45.45%
$13 TruScreen Continues Strong Sales Growth in Q3 FY2024 25 Jan 2024 7:30AM $0.022 $0.012 fallen by 45.45%
$13 TruScreen Wins Top Award Mother and Child Challenge Poland 14 Dec 2023 8:58AM $0.022 $0.012 fallen by 45.45%
$13 TuuScreen Included on Vietnamese MOH Approved Technical List 13 Dec 2023 8:40AM $0.022 $0.012 fallen by 45.45%
$13 TruScreen Awarded Zimbabwe Tender 6 Nov 2023 8:03AM $0.021 $0.012 fallen by 42.86%
$13 Half Yearly Report and Accounts 6 Nov 2023 7:09AM $0.021 $0.012 fallen by 42.86%
$13 Directors Change of Interest Notices X 4 20 Oct 2023 10:44AM $0.022 $0.012 fallen by 45.45%
$13 Appendix 2A 20 Oct 2023 10:42AM $0.022 $0.012 fallen by 45.45%
$13 Appendix 3G 20 Oct 2023 10:40AM $0.022 $0.012 fallen by 45.45%
$13 Strong Sales growth in China in Improved Half Year Results 12 Oct 2023 8:54AM $0.024 $0.012 fallen by 50%
$13 TruScreen - Commercial Breakthrough in Saudi Arabia 18 Sep 2023 7:30AM $0.020 $0.012 fallen by 40%

126 - 150 of 362 results

Page 6 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.